Alnylam Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Alnylam Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Alnylam Pharmaceuticals Inc
Rating: 1.154819375
Author: Trendlyne DVM scores

Momentum Trap

about

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...

469.18 -0.13 (-0.03%)

New 52W High in past week

346.2K

XNAS Volume

XNAS 11 Sep, 2025 1:25 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

4.8 / 100

Technically Moderately Bullish

65.3 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

434

1Yr Price target downside is -7%

27 analysts

Alnylam Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Alnylam Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...

New 52W High in past week

SWOT Analysis

Alnylam Pharmaceuticals Inc Live Price Chart